Nevertheless, our results in this study show that in melanoma cell lines and primary tumors with focal deletion at the CDKN2A/B locus, the transcription of MTAP-ANRIL fusion gene is a frequent occurrence. The gene discussed is CDKN2A; the disease is melanoma.